R M Dunn - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

R M Dunn

Showing results (41-50 of 43) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 43 results.

Cancer Research|September 1, 1995

Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivativesT M Behr, R M Sharkey, M E Juweid, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1997

Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgGT M Behr, R M Sharkey, M E Juweid, et al.

Cancer Immunology, Immunotherapy : CII|May 1, 1997

Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22R M Sharkey, T M Behr, M J Mattes, et al.

Pageof 5

Search research articles

Showing results (41-50 of 43) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 43 results.

Cancer Research|September 1, 1995

Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivativesT M Behr, R M Sharkey, M E Juweid, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1997

Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgGT M Behr, R M Sharkey, M E Juweid, et al.

Cancer Immunology, Immunotherapy : CII|May 1, 1997

Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22R M Sharkey, T M Behr, M J Mattes, et al.

Pageof 5